Wheezo
Cost Reduction of Manufacturing for Respiri's 'Wheezo'
Respiri Limited, a Melbourne-based eHealth Software as a Service (SaaS) company, was seeking to introduce their new innovative IoT medical product named ‘Wheezo’ into the global market.
Respiri has revolutionized asthma management with ‘Wheezo’ however required a partner to help them reduce the manufacturing cost and bring the product to market faster.
Challenge
After years of product development and considering the high hardware costs, Respiri took a crucial decision: to change the manufacturing partner. In February, the company engaged Entech Electronics to manufacture their innovative device at reduced production costs.
Approach
The Respiri design team in Melbourne, Entech’s onshore team in Adelaide, and the ffshore team in China collaborated between April and August 2020. Regular project meetings to optimise Wheezo for manufacturing and work schedules were made between Melbourne, Adelaide, and Shenzhen using virtual meeting platforms.
Outcomes
- 85% reduction in total hardware cost
- Reduced overall material lead-times
- Creating customer visibility to the total supply chain network
- A substantial reduction in assembly and test times meaning improved turn-around times
- Raw materials pipeline implemented securing production and Wheezo availability.
- Optimized Bill of Materials (BOM) improving buying power and reducing MOQ exposure
